To pretreat or not to pretreat? The experience of three Italian Psoriasis centres on the use of premedication with Infliximab.
Division of Dermatology, Department of Specialistic, Clinical and Experimental Medicine, University of Bologna, Bologna, Italy.
F
F
Bardazzi
Dermatology Unit, Azienda Unità Sanitaria Locale della Romagna, Ravenna, Italy.
F
F
Savoia
Dermatology Unit, Arcispedale Santa Maria Nuova, IRCCS, Reggio Emilia, Italy.
V
V
Di Lernia
Division of Dermatology, Department of Specialistic, Clinical and Experimental Medicine, University of Bologna, Bologna, Italy.
V
V
Tengattini
Division of Dermatology, Department of Specialistic, Clinical and Experimental Medicine, University of Bologna, Bologna, Italy.
R
R
Balestri
Division of Dermatology, Department of Specialistic, Clinical and Experimental Medicine, University of Bologna, Bologna, Italy.
A
A
Patrizi
Division of Dermatology, Department of Specialistic, Clinical and Experimental Medicine, University of Bologna, Bologna, Italy. michela.magnano@gmail.com.
M
M
Magnano
D000328:Adult; D000368:Aged; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000069285:Infliximab / Q000008:administration & dosage / Q000627:therapeutic use*; D007558:Italy; D008297:Male; D008875:Middle Aged; D011292:Premedication; D011565:Psoriasis / Q000188:drug therapy*; D055815:Young Adult
D003879:Dermatologic Agents; D000069285:Infliximab